Annette Skinhøj

Title: Innovations in Pharmaceutical Composition by Annette Skinhøj

Introduction

Annette Skinhøj is a notable inventor based in Rødovre, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. Her work focuses on improving the therapeutic efficacy of medications, specifically for conditions such as orthostatic hypotension and urinary incontinence.

Latest Patents

Annette Skinhøj holds a patent for a controlled release pharmaceutical composition for oral use containing midodrine and/or its active metabolite, desglymidodrine. This innovative composition is designed to release the active ingredients in a manner that allows for optimal absorption in the gastrointestinal tract. The formulation aims to achieve a fast peak plasma concentration followed by a sustained release, maintaining therapeutic levels for an extended period. This approach helps mitigate side effects associated with midodrine, particularly supine hypertension.

Career Highlights

Annette Skinhøj is associated with Nycomed Austria GmbH, where she has contributed her expertise in pharmaceutical development. Her work has been instrumental in advancing the understanding of drug release mechanisms and improving patient outcomes through innovative formulations.

Collaborations

Throughout her career, Annette has collaborated with esteemed colleagues, including Peder Mohr Olsen and Poul Egon Bertelsen. These partnerships have fostered a collaborative environment that enhances the research and development of pharmaceutical innovations.

Conclusion

Annette Skinhøj's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medicine. Her work on controlled release compositions not only advances therapeutic options but also improves the quality of life for patients.